ℹ️ What is the future of clinical medicine as we see it ?
In the era of Genomics & AI, will most doctors of the future treat disease or will clinicians focus on precision health for individuals before disease strikes?
💬 Would like to hear your thoughts ?
The Clinical Interpretation of Variants in Cancer (CIViC) track for hg19/GRCh37 and hg38/GRCh38 is now available. The details page for a feature will list diseases and therapies that have been associated with a genomic variant.
Learn more at:
https://t.co/RsLdZix3ks
Happy to share BRCAIndica, our endeavour in making ACMG-AMP pathogenicity classifications available for over 10,000 BRCA1/2 variants.
@vinodscaria@anu_iris@kavitapandhare
https://t.co/2wtH7QPbhE
Aastha Vatsyayan (Registration No. 10BB20J02014) Ph.D. student of AcSIR will defend thesis entitled “Population-scale genomics for familial cancer syndromes” on October 10, 2024 at CSIR-Institute of Genomics and Integrative Biology, New Delhi Ph.D work was completed under the supervision of Dr. Vinod Scaria, AcSIR/CSIR-IGIB, New Delhi @CSIR_IND@IGIBSOCIAL
I had the pleasure to talk on Diagnostic #WholeGenomeSequencing and genomic #NewbornScreening - Is the time now ? in the Association of Child Neurologists (AOCN) Neurogenetics Webinar series. ⏱️ The 60 mins abridged session is now online.
https://t.co/tcODHY9N1h
It's time to turn the spotlight on!
We're delighted to present our esteemed speaker at #ETHealthIDS, Dr. Binukumar BK, Principal Scientist, CSIR-Institute of Genomics and Integrative Biology (IGIB), New Delhi
@IGIBSocial
Register Now - https://t.co/0Ohlbx72Ty
#ETIDS
30 years after the discovery and cloning of the cancer susceptibility gene BRCA1, William Foulkes reflects on this defining moment for breast and ovarian cancer genetics and how far the field has come
🦀 What are the recommendations for Next Generation Sequencing in Advanced Cancers ?
Summarising the highlights of the 2024 ESMO Precision Medicine Working Group Recommendations.
https://t.co/NYn0G6FitJ
Glad to share that our collaborative endeavor leveraging AI/ML approaches for classification of Wilson's Disease variants has been published!
Read here: https://t.co/xbaDQ96xCh
@sainimukesh795@bhaskar@vinodscaria@bk_binukumar
Can #AI/ML accelerate the classification of variants of unknown significance (#VUS) and keep pace with the genomic discoveries ?
We show that a well curated and clinically classified variant database can go in a big way to enable this at scale.
Can #AI/ML accelerate the classification of variants of unknown significance (#VUS) and keep pace with the genomic discoveries ?
We show that a well curated and clinically classified variant database can go in a big way to enable this at scale.
Why we should not be too worried by the 'rare' events and politicise vaccines.
What we need to ponder is how we need to build a better and transparent adverse event reporting system.
https://t.co/WbrvCuAF6z
PhD Position open in our lab!
We use #zebrafish models to dig deeper into the mechanisms of human disorders of #neurodevelopment#brain#development
Visit our page https://t.co/xNOQSjeHEb
@IGIBSocial
apply here https://t.co/kQ8ydEqIr7